Literature DB >> 34063951

Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update.

Pía Loren1, Nicolás Saavedra1, Kathleen Saavedra1, Tomás Zambrano2, Patricia Moriel3, Luis A Salazar1.   

Abstract

Cisplatin is an antineoplastic drug used for the treatment of many solid tumors. Among its various side effects, nephrotoxicity is the most detrimental. In recent years, epigenetic regulation has emerged as a modulatory mechanism of cisplatin-induced nephrotoxicity, involving non-coding RNAs, DNA methylation and histone modifications. These epigenetic marks alter different signaling pathways leading to damage and cell death. In this review, we describe how different epigenetic modifications alter different pathways leading to cell death by apoptosis, autophagy, necroptosis, among others. The study of epigenetic regulation is still under development, and much research remains to fully determine the epigenetic mechanisms underlying cell death, which will allow leading new strategies for the diagnosis and therapy of this disease.

Entities:  

Keywords:  DNA methylation; epigenetics; histone modification; nephrotoxicity; non-coding RNA

Year:  2021        PMID: 34063951     DOI: 10.3390/ph14060491

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  111 in total

1.  Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury.

Authors:  Chan Gyu Lee; Jin Geol Kim; Hyun Joo Kim; Hyuk-Kwon Kwon; Il Je Cho; Dal Woong Choi; Woo Hyung Lee; Won Dong Kim; Se Jin Hwang; Sangdun Choi; Sang Geon Kim
Journal:  Kidney Int       Date:  2014-04-23       Impact factor: 10.612

2.  Identification of microRNA-mRNA networks involved in cisplatin-induced renal tubular epithelial cells injury.

Authors:  Jie Wu; Dan-Dan Li; Jia-Yao Li; Yi-Cong Yin; Peng-Chang Li; Ling Qiu; Li-Meng Chen
Journal:  Eur J Pharmacol       Date:  2019-02-12       Impact factor: 4.432

3.  MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism.

Authors:  Weitang Liao; Zongjie Fu; Yanfang Zou; Dan Wen; Hongkun Ma; Fangfang Zhou; Yongxi Chen; Mingjun Zhang; Wen Zhang
Journal:  Exp Cell Res       Date:  2017-09-18       Impact factor: 3.905

4.  Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease.

Authors:  Sarah I Landau; Xiaojia Guo; Heino Velazquez; Richard Torres; Eben Olson; Rolando Garcia-Milian; Gilbert W Moeckel; Gary V Desir; Robert Safirstein
Journal:  Kidney Int       Date:  2019-04       Impact factor: 10.612

5.  MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-β.

Authors:  Jielu Hao; Qiang Lou; Qingqing Wei; Shuqin Mei; Lin Li; Guangyu Wu; Qing-Sheng Mi; Changlin Mei; Zheng Dong
Journal:  J Biol Chem       Date:  2017-01-24       Impact factor: 5.157

6.  Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death.

Authors:  Wei Qian; Manabu Nishikawa; Anwarul Md Haque; Masaki Hirose; Masayuki Mashimo; Eisuke Sato; Masayasu Inoue
Journal:  Am J Physiol Cell Physiol       Date:  2005-08-17       Impact factor: 4.249

7.  Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.

Authors:  D Li; Y Zhang; Y Xie; J Xiang; Y Zhu; J Yang
Journal:  Cancer Gene Ther       Date:  2013-03-08       Impact factor: 5.987

8.  Upregulation of AMWAP: a novel mechanism for HDAC inhibitors to protect against cisplatin nephrotoxicity.

Authors:  Jinhua Tang; Shougang Zhuang
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

9.  miR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injury.

Authors:  M S Joo; C G Lee; J H Koo; S G Kim
Journal:  Cell Death Dis       Date:  2013-10-31       Impact factor: 8.469

10.  MicroRNA-205 inhibits renal cells apoptosis via targeting CMTM4.

Authors:  Hongxia Zhang; Xiaoning Zhang; Xiaoying Yuan; Linna Wang; Ying Xiao
Journal:  Iran J Basic Med Sci       Date:  2015-10       Impact factor: 2.699

View more
  4 in total

Review 1.  Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stress.

Authors:  Jean C Bikomeye; Janée D Terwoord; Janine H Santos; Andreas M Beyer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-05       Impact factor: 5.125

Review 2.  Therapies Targeting Epigenetic Alterations in Acute Kidney Injury-to-Chronic Kidney Disease Transition.

Authors:  Fumiaki Tanemoto; Imari Mimura
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-20

Review 3.  Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within.

Authors:  Abdul Basit Baba; Bilal Rah; Gh Rasool Bhat; Ifra Mushtaq; Sabra Parveen; Rukhsana Hassan; Mahrukh Hameed Zargar; Dil Afroze
Journal:  Front Pharmacol       Date:  2022-02-28       Impact factor: 5.810

Review 4.  Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity.

Authors:  Azza El-Sheikh; Zenat Khired
Journal:  Medicina (Kaunas)       Date:  2021-12-28       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.